Stephen Cornelissen on 20th Strategic Blood Forum from Australian Red Cross Lifeblood
Stephen Cornelissen, CEO of Australian Red Cross Lifeblood, shared on LinkedIn:
”It was wonderful to come together this week with global and local experts from government, clinical practice, industry, and the community for the 20th Strategic Blood Forum, hosted by Australian Red Cross Lifeblood.
The Forum provided a valuable opportunity to share knowledge and explore global trends in blood product supply, demand, policy, and innovation and consider their relevance to Australia. At Lifeblood, we are committed to driving meaningful change for the health and wellbeing of Australians today, tomorrow and well into the future.
A special thank you to our ambassador Michael Klim for sharing his insights as a recipient of the plasma derived product IVIg, along with his partner Michelle who also presented.
Demand is growing for this product, and we are grateful for all our plasma donors.”
Stay updated with Hemostasis Today.
-
Sep 6, 2026, 18:17Aryabhatta Sadhu: Irradiation of Blood Components – From Clinical Indication to Laboratory Release
-
Sep 6, 2026, 18:15Ashenafi Tazebew Amare: A Year of Progress, Transformation and Renewed Commitment
-
Sep 6, 2026, 18:13Emilio Osorio: Can Anticoagulation Be Safely Discontinued After Surgical Left Atrial Appendage Occlusion?
-
Sep 6, 2026, 18:11Razan Alolyani: Our Research on Anticoagulation After Acute Ischemic Stroke Receives 2nd Place
-
Sep 6, 2026, 18:10Chayakrit Krittanawong: Have You Heard of Blood Clots in the Legs?
-
Sep 6, 2026, 18:08Trilok Chand: Microplastics Found in Human Testes and Blood Clots
-
Sep 6, 2026, 18:07Sarah Moharem Elgamal: Cardiovascular Imaging Beyond Anatomy Toward Earlier Risk Prediction
-
Sep 6, 2026, 16:41Christina P.: APS – How it Happens in Your Blood, the Warning Signs, and What to Do about It
-
Sep 6, 2026, 16:33Jose Angel Nicolas Avila: How Tissue Mitochondrial Activity Dictates Macrophage Pool Size